Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone turnover in untreated polymyalgia rheumatica.

T C Barnes1, A Daroszewska, W D Fraser

  • 1Department of Rheumatology, Royal Liverpool University Hospital, Liverpool, UK. tbarnes@doctors.org.uk

Rheumatology (Oxford, England)
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Periconceptional and Gestational Vitamin D3 Restriction on Fetal Folliculogenesis and Anti-Mullerian Hormone Secretion Using Sheep as a Model.

Reproduction in domestic animals = Zuchthygiene·2024
Same author

Prevalence, incidence and determinants of QuantiFERON<sup>TM</sup> positivity in South African schoolchildren.

IJTLD open·2024
Same author

Sedentary behaviour and bone health in older adults: a systematic review.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Hormonal contraceptive use, bone density and biochemical markers of bone metabolism in British Army recruits.

BMJ military health·2021
Same author

The effects of short-term low energy availability, achieved through diet or exercise, on cognitive function in oral contraceptive users and eumenorrheic women.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2021
Same author

Gestational hypercalcemia: Prevalence and biochemical profile.

The Journal of steroid biochemistry and molecular biology·2020
Same journal

Vaccination coverage of influenza and pneumococcal vaccines in patients with rheumatic diseases: a systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026
Same journal

Comment on: Distinct cytokine and cytokine receptor expression patterns characterise different forms of myositis.

Rheumatology (Oxford, England)·2026
Same journal

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026
Same journal

Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluation.

Rheumatology (Oxford, England)·2026
Same journal

Mechanisms, clinical manifestations and management of cardiovascular diseases in ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2026
Same journal

Clinical and autoantibody associations with malignancy in systemic sclerosis: A systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026
See all related articles

Polymyalgia rheumatica (PMR) patients show increased bone resorption and decreased bone formation before treatment, suggesting uncoupled bone turnover. Steroid treatment effects on bone metabolism in PMR require further investigation.

Area of Science:

  • Rheumatology
  • Bone Metabolism
  • Geriatric Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a prevalent inflammatory condition in the elderly.
  • PMR is linked to increased bone resorption, potentially due to systemic inflammation.
  • Steroid therapy has shown promise in ameliorating bone resorption in PMR patients.

Purpose of the Study:

  • To investigate bone formation and resorption markers in PMR patients before any treatment.
  • To assess the relationship between disease activity and bone turnover markers in PMR.

Main Methods:

  • Measured bone resorption using urinary free pyridinoline (fPYD) and deoxypyridinoline (fDPD).
  • Assessed bone formation via serum procollagen type 1 N-terminal propeptide (P1NP).
  • Evaluated disease activity with inflammatory markers (ESR, CRP) and bone mineral density (DXA scan).

Related Experiment Videos

Main Results:

  • PMR patients exhibited significantly elevated bone resorption markers (fPYD, fDPD) pre-treatment.
  • Bone formation markers (P1NP) were significantly decreased in PMR patients compared to controls.
  • No significant loss in bone mineral density was detected at baseline.

Conclusions:

  • Bone turnover appears uncoupled in PMR, with resorption exceeding formation.
  • The disease process alone may lead to long-term skeletal mass reduction.
  • Further research is needed on steroid treatment's impact on bone metabolism and long-term outcomes in PMR.